Supernus Pharmaceuticals | SUPN - Stock


Supernus Pharmaceuticals reported $107.1M in Stock for its fiscal quarter ending in September of 2025.





Stock Change Date
Abbott USD 6.71B 246M Sep/2025
ANI Pharmaceuticals USD 146.48M 8.16M Sep/2025
Aurora Cannabis CAD 221.96M 6.3M Sep/2025
Bristol-Myers Squibb USD 2.76B 21M Sep/2025
Canopy Growth CAD 102.37M 8.55M Sep/2025
Corcept Therapeutics USD 12.35M 73K Sep/2025
Eisai JPY 227.32B 11.41B Jun/2025
Eli Lilly USD 12.18B 1.17B Sep/2025
Novo Nordisk DKK 45.65B 21.26B Jun/2025
Pacira USD 157.68M 9.52M Sep/2025
Perrigo USD 1.23B 11.5M Sep/2025
Pfizer USD 11.47B 201M Sep/2025
Supernus Pharmaceuticals USD 107.1M 63.08M Sep/2025
United Therapeutics USD 176.5M 7.3M Sep/2025
Xeris Pharmaceuticals USD 67.46M 182K Sep/2025